Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Incontinentia pigmenti.

Annals of Saudi medicine

Al-Khenaizan S.
PMID: 17264639
Ann Saudi Med. 2000 Sep-Nov;20(5):424-6. doi: 10.5144/0256-4947.2000.424.

No abstract available.

Cite
Al-Khenaizan S. Incontinentia pigmenti. Ann Saudi Med. 2000;20(5):424-6doi: 10.5144/0256-4947.2000.424.
Al-Khenaizan, S. (2000). Incontinentia pigmenti. Annals of Saudi medicine, 20(5), 424-6. https://doi.org/10.5144/0256-4947.2000.424
Al-Khenaizan, S. "Incontinentia pigmenti." Annals of Saudi medicine vol. 20,5 (2000): 424-6. doi: https://doi.org/10.5144/0256-4947.2000.424
Al-Khenaizan S. Incontinentia pigmenti. Ann Saudi Med. 2000 Sep-Nov;20(5):424-6. doi: 10.5144/0256-4947.2000.424. PMID: 17264639.
Copy Download .nbib Format: NLM
Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations.

Therapeutics and clinical risk management

Nashabat M, Al-Khenaizan S, Alfadhel M.
PMID: 29440907
Ther Clin Risk Manag. 2018 Feb 02;14:225-229. doi: 10.2147/TCRM.S151732. eCollection 2018.

Methionine adenosyltransferase (MAT) I/III deficiency (OMIM # 250850) is caused by a mutation in

Cite
Nashabat M, Al-Khenaizan S, Alfadhel M. Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations. Ther Clin Risk Manag. 2018;14:225-229doi: 10.2147/TCRM.S151732.
Nashabat, M., Al-Khenaizan, S., & Alfadhel, M. (2018). Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations. Therapeutics and clinical risk management, 14225-229. https://doi.org/10.2147/TCRM.S151732
Nashabat, Marwan, et al. "Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations." Therapeutics and clinical risk management vol. 14 (2018): 225-229. doi: https://doi.org/10.2147/TCRM.S151732
Nashabat M, Al-Khenaizan S, Alfadhel M. Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations. Ther Clin Risk Manag. 2018 Feb 02;14:225-229. doi: 10.2147/TCRM.S151732. eCollection 2018. PMID: 29440907; PMCID: PMC5798556.
Copy Download .nbib Format: NLM
Topical timolol for vasculitis ulcer: A potential healing approach.

JAAD case reports

Alsaad AMS, Alsaad SM, Fathaddin A, Al-Khenaizan S.
PMID: 31508472
JAAD Case Rep. 2019 Aug 30;5(9):812-814. doi: 10.1016/j.jdcr.2019.07.016. eCollection 2019 Sep.

No abstract available.

Cite
Alsaad AMS, Alsaad SM, Fathaddin A, et al. Topical timolol for vasculitis ulcer: A potential healing approach. JAAD Case Rep. 2019;5(9):812-814doi: 10.1016/j.jdcr.2019.07.016.
Alsaad, A. M. S., Alsaad, S. M., Fathaddin, A., & Al-Khenaizan, S. (2019). Topical timolol for vasculitis ulcer: A potential healing approach. JAAD case reports, 5(9), 812-814. https://doi.org/10.1016/j.jdcr.2019.07.016
Alsaad, Abdulaziz M S, et al. "Topical timolol for vasculitis ulcer: A potential healing approach." JAAD case reports vol. 5,9 (2019): 812-814. doi: https://doi.org/10.1016/j.jdcr.2019.07.016
Alsaad AMS, Alsaad SM, Fathaddin A, Al-Khenaizan S. Topical timolol for vasculitis ulcer: A potential healing approach. JAAD Case Rep. 2019 Aug 30;5(9):812-814. doi: 10.1016/j.jdcr.2019.07.016. eCollection 2019 Sep. PMID: 31508472; PMCID: PMC6726845.
Copy Download .nbib Format: NLM
Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia.

International journal of general medicine

Korayem GB, Alkanhal R, Almass R, Alkhunaizan S, Alharthi G, Bin Sheraim N, Alqahtani S, Alkofide H.
PMID: 34511990
Int J Gen Med. 2021 Aug 30;14:5079-5089. doi: 10.2147/IJGM.S328914. eCollection 2021.

PURPOSE: To identify factors associated with inappropriate acid-suppressive therapy (AST) use in hospitalized medical ward patients.PATIENTS AND METHODS: This was a combined retrospective cohort study reviewing the electronic medical records of medical ward in a secondary university hospital between...

Cite
Korayem GB, Alkanhal R, Almass R, et al. Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia. Int J Gen Med. 2021;14:5079-5089doi: 10.2147/IJGM.S328914.
Korayem, G. B., Alkanhal, R., Almass, R., Alkhunaizan, S., Alharthi, G., Bin Sheraim, N., Alqahtani, S., & Alkofide, H. (2021). Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia. International journal of general medicine, 145079-5089. https://doi.org/10.2147/IJGM.S328914
Korayem, Ghazwa B, et al. "Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia." International journal of general medicine vol. 14 (2021): 5079-5089. doi: https://doi.org/10.2147/IJGM.S328914
Korayem GB, Alkanhal R, Almass R, Alkhunaizan S, Alharthi G, Bin Sheraim N, Alqahtani S, Alkofide H. Patients, Prescribers, and Institutional Factors Associated with Inappropriate Use of Acid Suppressive Therapy in Medical Wards: An Experience of a Single-Center in Saudi Arabia. Int J Gen Med. 2021 Aug 30;14:5079-5089. doi: 10.2147/IJGM.S328914. eCollection 2021. PMID: 34511990; PMCID: PMC8416456.
Copy Download .nbib Format: NLM
Propranolol-induced hyperkalemia in the management of infantile hemangioma.

JAAD case reports

Al-Rwebah H, Alkhodair R, Al-Khenaizan S.
PMID: 32258322
JAAD Case Rep. 2020 Mar 25;6(4):359-361. doi: 10.1016/j.jdcr.2020.01.028. eCollection 2020 Apr.

No abstract available.

Cite
Al-Rwebah H, Alkhodair R, Al-Khenaizan S. Propranolol-induced hyperkalemia in the management of infantile hemangioma. JAAD Case Rep. 2020;6(4):359-361doi: 10.1016/j.jdcr.2020.01.028.
Al-Rwebah, H., Alkhodair, R., & Al-Khenaizan, S. (2020). Propranolol-induced hyperkalemia in the management of infantile hemangioma. JAAD case reports, 6(4), 359-361. https://doi.org/10.1016/j.jdcr.2020.01.028
Al-Rwebah, Huda, et al. "Propranolol-induced hyperkalemia in the management of infantile hemangioma." JAAD case reports vol. 6,4 (2020): 359-361. doi: https://doi.org/10.1016/j.jdcr.2020.01.028
Al-Rwebah H, Alkhodair R, Al-Khenaizan S. Propranolol-induced hyperkalemia in the management of infantile hemangioma. JAAD Case Rep. 2020 Mar 25;6(4):359-361. doi: 10.1016/j.jdcr.2020.01.028. eCollection 2020 Apr. PMID: 32258322; PMCID: PMC7103665.
Copy Download .nbib Format: NLM
Ichthyosis Prematurity Syndrome: A Rare Form but Easily Recognizable Ichthyosis.

Case reports in dermatology

Al-Khenaizan S, AlSwailem A, AlBalwi MA.
PMID: 34720920
Case Rep Dermatol. 2021 Sep 21;13(3):470-473. doi: 10.1159/000519035. eCollection 2021.

Ichthyosis prematurity syndrome is a rare autosomal recessive genodermatosis that is associated with mutations in the

Cite
Al-Khenaizan S, AlSwailem A, AlBalwi MA. Ichthyosis Prematurity Syndrome: A Rare Form but Easily Recognizable Ichthyosis. Case Rep Dermatol. 2021;13(3):470-473doi: 10.1159/000519035.
Al-Khenaizan, S., AlSwailem, A., & AlBalwi, M. A. (2021). Ichthyosis Prematurity Syndrome: A Rare Form but Easily Recognizable Ichthyosis. Case reports in dermatology, 13(3), 470-473. https://doi.org/10.1159/000519035
Al-Khenaizan, Sultan, et al. "Ichthyosis Prematurity Syndrome: A Rare Form but Easily Recognizable Ichthyosis." Case reports in dermatology vol. 13,3 (2021): 470-473. doi: https://doi.org/10.1159/000519035
Al-Khenaizan S, AlSwailem A, AlBalwi MA. Ichthyosis Prematurity Syndrome: A Rare Form but Easily Recognizable Ichthyosis. Case Rep Dermatol. 2021 Sep 21;13(3):470-473. doi: 10.1159/000519035. eCollection 2021. PMID: 34720920; PMCID: PMC8525308.
Copy Download .nbib Format: NLM
Implantation of a cardiac pacemaker to circumvent complete heart block in a life-threatening hemangioma to allow the use of propranolol.

JAAD case reports

Al-Khenaizan S, Faqeeh H.
PMID: 31646159
JAAD Case Rep. 2019 Sep 24;5(10):844-845. doi: 10.1016/j.jdcr.2019.06.029. eCollection 2019 Oct.

No abstract available.

Cite
Al-Khenaizan S, Faqeeh H. Implantation of a cardiac pacemaker to circumvent complete heart block in a life-threatening hemangioma to allow the use of propranolol. JAAD Case Rep. 2019;5(10):844-845doi: 10.1016/j.jdcr.2019.06.029.
Al-Khenaizan, S., & Faqeeh, H. (2019). Implantation of a cardiac pacemaker to circumvent complete heart block in a life-threatening hemangioma to allow the use of propranolol. JAAD case reports, 5(10), 844-845. https://doi.org/10.1016/j.jdcr.2019.06.029
Al-Khenaizan, Sultan, and Faqeeh, Hashem. "Implantation of a cardiac pacemaker to circumvent complete heart block in a life-threatening hemangioma to allow the use of propranolol." JAAD case reports vol. 5,10 (2019): 844-845. doi: https://doi.org/10.1016/j.jdcr.2019.06.029
Al-Khenaizan S, Faqeeh H. Implantation of a cardiac pacemaker to circumvent complete heart block in a life-threatening hemangioma to allow the use of propranolol. JAAD Case Rep. 2019 Sep 24;5(10):844-845. doi: 10.1016/j.jdcr.2019.06.029. eCollection 2019 Oct. PMID: 31646159; PMCID: PMC6804439.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries